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Abstract
Background: Based on results of earlier studies, brain, heart and kidney are most commonly used for West Nile virus
(WNV) detection in avian species. Both monoclonal and polyclonal antibodies have been used for the
immunohistochemical diagnosis of WNV in these species. Thus far, no studies have been performed to compare the
sensitivity and specificity of monoclonal and polyclonal antibodies in detecting WNV in American crows (Corvus
brachyrhynchos). Our objectives were to determine 1) the comparative sensitivities of monoclonal and polyclonal
antibodies for immunohistochemical (IHC) diagnosis of WNV infection in free-ranging American crows, 2) which
organ(s) is/are most suitable for IHC-based diagnosis of WNV, and 3) how real-time RT-PCR on RNA extracted from
formalin-fixed paraffin-embedded tissues compared to IHC for the diagnosis of WNV infection.
Methods: Various combinations, depending on tissue availability, of sections of heart, kidney, brain, liver, lung, spleen,
and small intestine from 85 free-ranging American crows were stained using a rabbit-polyclonal anti-WNV antibody as
well as a monoclonal antibody directed against an epitope on Domain III of the E protein of WNV. The staining intensity
and the extent of staining were determined for each organ using both antibodies. Real-time RT-PCR on formalin-fixed
paraffin-embedded tissues from all 85 crows was performed.
Results: Forty-three crows were IHC-positive in at least one of the examined organs with the polyclonal antibody, and
of these, only 31 were positive when IHC was performed with the monoclonal antibody. Real-time RT-PCR amplified
WNV-specific sequences from tissue extracts of the same 43 crows that were IHC-positive using the polyclonal antibody.
All other 42 crows tested negative for WNV with real-time PCR and IHC staining. Both antibodies had a test specificity
of 100% when compared to PCR results. The test sensitivity of monoclonal antibody-based IHC staining was only 72%,
compared to 100% when using the polyclonal antibody.
Conclusion: The most sensitive, readily identified, positively staining organs for IHC are the kidney, liver, lung, spleen,
and small intestine. Real-time RT-PCR and IHC staining using a polyclonal antibody on sections of these tissues are highly
sensitive diagnostic tests for the detection of WNV in formalin-fixed tissues of American crows.
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Background
West Nile virus (WNV) first emerged in the Western hem-
isphere during the 1999 New York City outbreak and has
since spread across the United States, into Canada, and to
the Caribbean Islands and Central America [1-6]. This
virus is expected to spread throughout South America in
the next few years [7]. The New York WNV strain is closely
related to the virulent WN-Israel 1998 virus strain isolated
from a goose [8], which may explain the surprisingly high
number of avian fatalities, especially among American
crows (Corvus brachyrhynchos), following the 1999 New
York City outbreak [1,4]. The North American WNV epiz-
ootic caused fatal disease in more than 200 avian species
as well as in reptilian, and mammalian species, including
humans [1,4,9-16]. Mortality rates in some avian species,
such as corvids, can approach 100% [17]. These unusually
high mortality rates may be due to the introduction of
WNV in naïve avian populations, or due to the emergence
of a new virulent strain [1-4].
The identification of WNV-positive birds has been shown
to be the earliest indicator of WNV in an area [18]. Amer-
ican crows (AMCRs) are the most sensitive sentinel spe-
cies used to detect the presence of WNV in northern
regions [19-21]. However, in other regions, different spe-
cies have been shown to be more sensitive than the crow,
such as the blue jay in the Southern United States [21,22].
A study by the Centers for Disease Control and Prevention
(CDC), using data from 2002, found that in 379 of 527
counties (72%) reporting human West Nile meningoen-
cephalitis, the first reported human cases occurred a
median of 38.5 days after the first WNV-affected dead bird
had been found [23]. Corvids infected with WNV are usu-
ally found dead without any previously reported clinical
signs, or die within 24 hours of the onset of clinical signs.
Because of the acute onset and rapidly progressive nature
of the disease, significant gross and histologic lesions are
rarely observed at necropsy [4,24]. Therefore, appropriate
tissue collection and diagnostic testing are imperative for
accurate diagnosis and usefulness in a WNV surveillance
program.
To date, few studies have been performed to determine
appropriate tissue selection, test sensitivity and test specif-
icity for WNV surveillance. Earlier studies to determine
the best tissue(s) for WNV detection in AMCRs using RT-
PCR and virus isolation (VI) reported that virus was most
consistently detected in fresh samples of kidney and brain
[4,24,25]. In addition, the heart, lung, liver, kidneys, and
spleen were determined to be good organs for VI and RNA
detection [4,24]. Immunohistochemistry (IHC) has also
been documented as a reliable and efficient method of
identifying WNV in formalin-fixed avian tissues [4]. One
study reported that IHC using a polyclonal antibody was
comparable to VI for the detection of WNV in birds [26].
In another report, sections of heart, kidney, and spleen
were consistently positive using, VI, RT-PCR, and a poly-
clonal antibody for IHC staining [4]. As a result of these
studies and recommendations by the CDC, the brain,
heart and kidneys are used most commonly for WNV
detection in avian species [21]. While new molecular
WNV surveillance tests have been developed in recent
years, many veterinary diagnostic laboratories still use
immunohistochemistry as a primary method for WNV
surveillance in AMCRs.
The rabbit-polyclonal anti-WNV antibody, that has been
used for IHC staining in most studies,, is not specific for
WNV, and can detect other flaviviruses (including St.
Louis encephalitis virus) [4]. In contrast, a commercially
available monoclonal anti-WNV antibody (7H2) has
been shown to be specific for the detection of WNV. One
study, using this antibody for IHC staining, reported that
sections of heart and kidney were just as reliable for the
diagnosis of WNV infection as RT-PCR performed on fresh
brain tissue in AMCRs. Other tissues (bone marrow, duo-
denum, proventriculus, liver, lung, spleen, pancreas, and
brain) used for IHC staining were not as reliable [27]. In
another recent study, using the same monoclonal anti-
body, it was reported that kidney and spleen were more
often positive than brain and skin in infected birds; how-
ever, none of the tissues could consistently identify a pos-
itive bird and the authors did not recommend the use of
this monoclonal antibody for immunohistochemical
WNV surveillance [28]. Thus far, no studies have been per-
formed to directly compare the sensitivity and specificity
of a monoclonal antibody to a polyclonal antibody for
detection of WNV in AMCRs.
The objectives of this study were to determine: 1) if there
is a significant difference in IHC staining for WNV using
monoclonal versus polyclonal antibodies in naturally
WNV-infected, free-ranging AMCRs, 2) which organ(s) is/
are the most appropriate for the detection of WNV infec-
tion by these IHC techniques, based upon sensitivity and
staining intensity, and 3) how real-time RT-PCR per-
formed on RNA extracted from formalin-fixed paraffin-
embedded tissues compared to IHC for the diagnosis of
WNV infection. Only IHC-positive crows that were con-
firmed WNV-positive by RT-PCR were considered, in
order to rule out cross-reaction with other flaviviruses.
Because of WNV's wide host range and continued spread
to new regions, ongoing assessment of surveillance tech-
niques is needed in order to generate accurate, useful data
for predicting the occurrence of human WNV infections.
Methods
Eighty five free-ranging AMCRs that had been found dead
in the State of Michigan during the summer of 2001, andBMC Infectious Diseases 2007, 7:49 http://www.biomedcentral.com/1471-2334/7/49
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had originally been submitted for WNV surveillance, were
used in this study.
Immunohistochemistry
IHC examination was performed for each of these 85
AMCRs using various combinations of sections of heart
(79), kidney (73), brain (54), liver (50), lung (42), spleen
(39), and small intestine (54). The sections chosen for
evaluation depended upon tissue availability for each
bird. Formalin-fixed tissues were trimmed, embedded in
paraffin, sectioned at 5 µm and routinely processed for
immunohistochemistry. An Enhanced V Red (Alkaline
Phosphatase Red) Detection System, (Ventana Medical
Systems, Inc., Tucson, AZ, USA) as well as bulk buffers
specifically designed for use on the BenchMark Auto-
mated Staining System, (Ventana Medical Systems, Inc.,
Tucson, AZ, USA) were used for immuno-labeling and vis-
ualization. Slides were baked in a drying oven at 60°C for
30 minutes. The slides were then barcode labeled, and
placed in the BenchMark for deparaffinization and heat-
induced epitope retrieval. Antigen retrieval was performed
using retrieval solution CC1 (Medical Systems, Inc., Tuc-
son, AZ, USA) with an 8-minute heating and an 8-minute
cooling cycle. A rabbit-polyclonal anti-WNV antibody
(BioReliance, Rockville, MD, USA) at a concentration of
1:2000 for 32 minutes, and, a commercially available
mouse-monoclonal anti-WNV antibody (clone 7H2),
directed against an epitope on Domain III of the E protein
of WNV (BioReliance, Rockville, MD, USA), at a concen-
tration of 1:2000 for 32 minutes were used as primary
antibodies. The slides were counterstained using Ventana
hematoxylin (Ventana Medical Systems, Inc., Tucson, AZ,
USA), and bluing for 2 minutes each, then dehydrated,
cleared and mounted. Formalin-fixed, paraffin-embedded
sections of heart and kidney from crows that had previ-
ously been tested for WNV infection using RT-PCR were
used as positive and negative controls.
Evaluation of immunohistochemical staining
Two board-certified pathologists (JSP and MK) independ-
ently reviewed all slides and identified each available
organ as either positive or negative by monoclonal and/or
polyclonal antibody staining. If at least one organ was
positive, the crow was determined to be positive for WNV
by IHC. In addition, each organ was evaluated for focal
versus diffuse staining, and the type(s) of cells that exhib-
ited positive staining in each organ was/were recorded. All
IHC-positive (monoclonal and/or polyclonal) organs
were subjectively evaluated for the percentage of positive
cells within an organ and the intensity of antibody stain-
ing. A value of 1, 2, or 3 was assigned to each IHC-positive
organ based on the approximate percentage of positive-
staining cells (including inflammatory cells) in each
organ. A value of 1 was assigned if less than 20% of the
cells within an organ stained positively; a value of 2 was
assigned if 20% to 80% of the cells within an organ
stained positively; a value of 3 was assigned if greater than
80% of the cells within an organ stained positively. In
addition, to determine IHC staining intensity, each organ
was assigned a value of 1, 2, or 3 based on the ease of iden-
tifying positive staining at a magnification of 2.5× on a
light microscope. A value of 1 was assigned if positive
staining could not be identified at 2.5× (but was identified
at higher magnification); a value of 2 was assigned if faint
positive staining could be identified at 2.5×; a value of 3
was assigned if positive staining was easily identified at
2.5×. Average scores for each organ, in each category, were
determined.
RT-PCR
Frozen tissue samples
Fresh frozen, pooled tissue samples from all IHC-positive
crows and 5 selected IHC-negative crows were submitted
to the Molecular Biology Section of the Michigan Depart-
ment of Community Health (MDCH) Laboratory, Lans-
ing, MI, for RT-PCR detection of WNV as previously
published [10,29]. RT-PCR was used as the gold standard
to confirm WNV infection in IHC-positive crows.
Formalin-fixed, paraffin-embedded tissue samples
At the time of data evaluation, fresh frozen tissues were no
longer available for any of the crows. Therefore, in order
to check for viral RNA in the tissues of the IHC negative
crows, SYBR Green-based Real-time RT-PCR was per-
formed on pooled, paraffin-embedded tissues from all 85
crows by the Virology Section of the Diagnostic Center for
Population and Animal Health at Michigan State Univer-
sity. Prior to RNA extraction, approximately 25 mg of tis-
sue were deparaffinized in 1 ml of Citrisolv (Fisher
Scientific International, Hampton, NH, USA), then
washed twice in 1 ml of 100% ethanol and air-dried for 10
minutes. Total RNA was extracted using the RNeasy Mini
Kit (QIAGEN, Inc., Valencia, CA, USA) and eluted in 50 µl
of RNAse-free water. RT-PCR was performed with an IQ5
real-time PCR detection system (Bio-Rad Laboratories,
Hercules, CA, USA) using the Quantitect SYBR Green RT-
PCR Kit (QIAGEN, Inc., Valencia, CA, USA). The primers
used for SYBR Green-based Real-time RT-PCR, 5'-TCG-
GGTCATTTGAAGTGTAGAGT-3' (forward) and 5'-
CCATCCGTGCCAGTGTACTGC-3' (reverse), amplify a
155-bp region of the envelope glycoprotein E gene of
WNV. Primers were at a 0.5 µM concentration in a 50 µl
reaction volume. Five µl of the extracted RNA was used as
template. Cycling conditions were: 50°C for 30 min,
95°C for 15 min, followed by 45 cycles of 94°C for 10 sec,
55°C for 30 sec and 72°C for 10 sec. A post-amplification
melt curve analysis was done to detect WNV-specific prod-
ucts with an approximate peak melting temperature of
80.5°C.BMC Infectious Diseases 2007, 7:49 http://www.biomedcentral.com/1471-2334/7/49
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Statistical analysis
The sensitivity and specificity of both the monoclonal and
the polyclonal antibody staining in comparison to the RT-
PCR (using formalin-fixed, paraffin-embedded tissues)
results were determined for specific organ samples. Differ-
ences in results between tests were assessed using Fisher's
Exact test. In addition to sensitivity and specificity, the
positive and negative predictive values were calculated for
the monoclonal and the polyclonal antibody staining for
specific organ samples.
Results
IHC and evaluation of immunohistochemical staining
Forty-three out of 85 crows showed IHC-positive staining,
in at least one of the examined organs, with the polyclonal
antibody and 31 of these 43 were IHC-positive with both
monoclonal and polyclonal techniques. No birds were
positive with only monoclonal antibody staining. In these
43 IHC-positive cases 97.5% (39/40) of the kidneys,
93.3% (14/15) of the spleens and only 35.3% (6/17) of
the brains examined were positive with the polyclonal
antibody. The heart, liver, lung, and small intestine were
positive in 100% (42/42, 15/15, 13/13, 18/18 respec-
tively) of the cases. Using the monoclonal antibody,
47.6% (20/42) of the hearts, 62.5% (25/40) of the kid-
neys, 66.7% (10/15) of the spleens, 29.4% (5/17) of the
brains, 66.7% (10/15) of the livers, 76.9% (10/13) of the
lungs, and 83.3% (15/18) of the small intestines exam-
ined were positive. Both pathologists scored all tissues
identically.
The pattern of staining, and the individual cell types
which stained positively, were also determined. Positive
staining for WNV was always intracytoplasmic. The lung
and kidneys exhibited intense multifocal staining (figure
1) and the liver, spleen, and small intestine exhibited
intense multifocal to diffuse staining. The heart most
commonly exhibited pale focal to diffuse staining, with
the exception of some sections exhibiting intense epicar-
dial and/or endocardial staining (figure 2). The brain
exhibited rare focal staining of individual neurons and
glial cells. Resident macrophages and intravascular blood
monocytes were the most common positive-staining cells
in all organs examined. This finding agrees with Wein-
gartl's study in experimentally-infected crows and sup-
ports the hypothesis that monocytes/macrophages are
target cells that help to spread the virus throughout many
tissues [30]. Within sections of kidney, there were multi-
focal areas of positive staining within interstitial stromal
cells, mononuclear inflammatory cells, and occasional
tubular and collecting duct epithelial cells. Staining in
lung sections was often patchy and appeared to surround
airways and vessels. Interstitial fibroblasts, intravascular
and interstitial mononuclear inflammatory cells,
sloughed bronchial epithelial cells, and occasional intact
bronchial epithelial cells exhibited positive staining.
Within sections of liver and spleen, the most commonly
staining cells were Kupffer cells and reticuloendothelial
cells. Staining of hepatocytes and splenic lymphocytes
was not noted. Within sections of small intestine, staining
of epithelial cells was intense and ranged from multifocal
(individual crypts and occasional villi) to diffuse (all
crypts and villi). Sections of heart usually exhibited pale
scattered staining of interstitial connective tissue cells,
interstitial mononuclear inflammatory cells and myofib-
ers. Occasional endothelial cells also showed positive
staining. Some sections exhibited intense staining of mac-
rophages within the epicardium and endocardium. Stain-
ing within sections of brain was often confined to neurons
and glial cells in focal areas. Occasional sections exhibited
staining within the meninges (perivascular connective tis-
sue cells and interstitial and intravascular mononuclear
inflammatory cells). These findings are similar to other
reports of cellular IHC staining for WNV in birds [4,22,25-
27,30].
Intense, multifocal, red immunohistochemical staining for  West Nile virus in the lung (A) and the kidney (B) using the  polyclonal antibody Figure 1
Intense, multifocal, red immunohistochemical staining for 
West Nile virus in the lung (A) and the kidney (B) using the 
polyclonal antibody.BMC Infectious Diseases 2007, 7:49 http://www.biomedcentral.com/1471-2334/7/49
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The numbers of organs assigned a specific score, based
upon the approximate percentage of positive staining cells
(including inflammatory cells), and the ease of positive
stain identification, using the polyclonal and the mono-
clonal antibody, are presented in Table 1. Average scores
for each organ in each category are presented in Table 2.
Based on these results, the organs that exhibited the high-
est percentage of positive staining cells with both antibod-
ies were the spleen, liver, lung, and small intestine. The
organs with the highest staining intensity (in which stain-
ing was easily identified at 2.5×), with both the mono-
clonal and the polyclonal antibody, were the same organs
that exhibited multifocal or diffuse staining, and include
the small intestine, spleen, lung, liver, and kidney.
RT-PCR
Frozen tissue samples tested by Taqman-based real-time RT-PCR
WNV RNA was detected in fresh frozen, pooled tissues
from all 43 of the IHC-positive crows by TaqMan RT-PCR
assay and was not detected in any of the 5 IHC negative
cases for a total of 43 confirmed WNV positive crows.
Formalin-fixed, Paraffin-embedded tissue samples tested by SYBR 
Green-based real-time RT-PCR
WNV RNA was detected in pooled, paraffin-embedded tis-
sues from all 43 of the IHC positive crows using this
method; this finding is consistent with the RT-PCR results
using pooled frozen tissue samples. WNV RNA was not
detected in any of the 42 IHC negative crows. These results
validated the use of formalin-fixed, paraffin-embedded
tissue samples for RT-PCR detection of WNV RNA.
Statistical analysis
Both monoclonal and polyclonal antibodies had a stain-
ing specificity of 100% when compared to PCR results
Pale, focal, red immunohistochemical staining for West Nile  virus in the myocardium (A) using the polyclonal antibody;  Intense, multifocal, red immunohistochemical staining for  West Nile virus in the endocardium (B) using the polyclonal  antibody Figure 2
Pale, focal, red immunohistochemical staining for West Nile 
virus in the myocardium (A) using the polyclonal antibody; 
Intense, multifocal, red immunohistochemical staining for 
West Nile virus in the endocardium (B) using the polyclonal 
antibody.
Table 1: Numbers of samples classified by ease of identification (staining intensity) and percentage of positive staining cells, by tissue 
type and IHC staining method
Tissue Staining 
Method
Number of samples classified by ease of identification at 2.5× Number of samples classified by percentage of 
positive cells
Unable Identifiable Easy < 20% 20–80% > 80%
Heart Monoclonal 10 9 1 20 0 0
Polyclonal 17 24 1 33 9 0
Kidney Monoclonal 1 16 8 23 2 0
Polyclonal 4 28 7 32 7 0
Brain Monoclonal 2 3 0 5 0 0
Polyclonal 5 1 0 6 0 0
Spleen Monoclonal 1 3 6 3 7 0
Polyclonal 0 6 8 2 12 0
Liver Monoclonal 1 7 2 6 4 0
Polyclonal 2 6 7 3 12 0
Lung Monoclonal 0 3 7 7 3 0
Polyclonal 0 7 6 8 5 0
Small 
Intestine
Monoclonal 0 5 10 8 4 3
Polyclonal 0 1 17 5 8 5BMC Infectious Diseases 2007, 7:49 http://www.biomedcentral.com/1471-2334/7/49
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(Table 3). The overall sensitivity of monoclonal IHC
staining was 72% (31 monoclonal positive crows/43 PCR
positive crows) and the sensitivity of polyclonal antibody
staining was 100%. The sensitivity of polyclonal antibody
staining was higher than monoclonal antibody staining
for all specific tissues tested, and 100% sensitivity was
achieved with polyclonal antibody staining of heart, liver,
lung, and small intestine samples. The sensitivity of poly-
clonal antibody staining was statistically significantly (p ≤
0.05) higher than monoclonal antibody staining for kid-
ney, brain, and small intestine tissue samples (Table 3).
The positive predictive values for both monoclonal and
polyclonal IHC staining were 100%, regardless of sample
type. Negative predictive values of polyclonal IHC stain-
ing were higher than those for monoclonal staining (fig-
ure 3). Interestingly, the difference in negative predictive
values for monoclonal and polyclonal staining of brain
tissues was relatively small (75.5% versus 77.1%, respec-
tively). The best negative predictive values were seen for
polyclonal antibody staining of the heart, liver, lungs, and
small intestine (100%).
Discussion
The test sensitivity of IHC staining for the detection of
WNV infection in AMCRs using a polyclonal antibody
with the Benchmark IHC System is superior to that of the
7H2 monoclonal antibody. When compared to RT-PCR
results, the sensitivity of monoclonal IHC staining was
72%, and the sensitivity of polyclonal IHC staining was
Table 3: Sensitivity and specificity of antibody staining techniques (monoclonal and polyclonal IHC) for the detection of WNV in avian 
tissue samples, using RT-PCR as a gold standard (n = 85, 43 positive, 42 negative by RT-PCR)
# of Samples Sensitivity Specificity
All Pos Neg Pt. Est. 95% C.I. Pt. Est. 95% C.I.
Overall* Monoclonal 85 31 54 72.1 57.3 – 83.3 100 91.6 – 100
Polyclonal 85 43 42 100 91.8 – 100 100 91.6 – 100
Heart Monoclonal 79 20 59 47.6 33.4 – 62.3 100 90.6 – 100
Polyclonal 79 42 37 100 91.6 – 100 100 90.6 – 100
Kidney* Monoclonal 73 25 48 62.5 47.0 – 75.8 100 89.6 – 100
Polyclonal 73 39 34 97.5 87.1 – 99.6 100 89.6 – 100
Brain* Monoclonal 54 5 49 29.4 13.3 – 53.1 100 90.6 – 100
Polyclonal 54 6 48 35.3 17.3 – 58.7 100 90.6 – 100
Spleen Monoclonal 38 10 28 66.7 41.7 – 84.8 100 85.7 – 100
Polyclonal 37 14 23 93.3 70.2 – 98.8 100 85.1 – 100
Liver Monoclonal 50 10 40 66.7 41.7 – 84.8 100 90.1 – 100
Polyclonal 50 15 35 100 79.6 – 100 100 90.1 – 100
Lung Monoclonal 40 10 30 76.9 49.7 – 91.8 100 87.5 – 100
Polyclonal 42 13 29 100 77.2 – 100 100 88.3 – 100
Small Intestine Monoclonal 50 15 35 83.3 60.8 – 94.2 100 89.3 – 100
Polyclonal 53 18 35 100.0 82.4 – 100 100.0 90.1 – 100
* Indicates statistically significant difference between monoclonal and polyclonal tests, Fisher's Exact p ≤ 0.05
Table 2: Average value assigned to each organ for staining intensity (ease of identification) and percentage of positive staining cells by 
tissue type and IHC staining method
Monoclonal Antibody Polyclonal Antibody
Ease of identification at 2.5×a Percentage of positive cellsb Ease of identification at 2.5×a Percentage of positive cellsb
Heart 1.55 1.00 1.62 1.21
Kidney 2.28 1.08 2.08 1.18
Brain 1.60 1.00 1.17 1.00
Spleen 2.50 1.70 2.57 1.86
Liver 2.10 1.40 2.33 1.80
Lung 2.70 1.30 2.46 1.38
Small intestine 2.67 1.67 2.94 2.00
a Ease of identification:
1 = positive staining could not be identified at 2.5× (but was identified at higher magnification); 2 = faint positive staining could be identified at 2.5×; 
3 = positive staining was easily identified at 2.5×
b Percentage of positive cells:
1 = less than 20% of the cells stained positively; 2 = 20% to 80% of the cells stained positively; 3 = greater than 80% of the cells stained positivelyBMC Infectious Diseases 2007, 7:49 http://www.biomedcentral.com/1471-2334/7/49
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100%. Therefore, the monoclonal antibody is not recom-
mended as a screening/surveillance test for WNV in
AMCRs. The polyclonal antibody was also significantly
more sensitive than the monoclonal antibody in detecting
WNV infection in each organ tested. However, it is impor-
tant to note that the polyclonal antibody has been shown
to detect other flaviviruses, whereas the monoclonal anti-
body does not. Even though the polyclonal antibody is
the superior antibody for WNV surveillance in AMCRs, its
use may be limited in geographical regions that harbor
other flaviviruses, and additional tests may be required to
exclude those viruses.
An interesting finding was the low percentage of IHC pos-
itive hearts using the monoclonal antibody (47.6%) com-
pared to the polyclonal antibody (100%). This difference
may be due to the relatively small amount of antigen
observed within heart sections. In spite of the high per-
centage of IHC-positive heart sections stained with the
polyclonal antibody, the percentage of positive cells in
sections of liver, lung, spleen, and small intestine was
greater than that seen in the heart. This correlates with the
finding that sections of kidney, lung, liver, spleen and
small intestine were far superior to sections of heart and
brain for the identification of positive WNV staining at
low magnification (2.5×) using both antibodies. The
intensity of staining depended, in part, upon the pattern
of IHC staining exhibited by each organ. Organs that
exhibited intense multifocal staining and intense diffuse
staining were most easily identified as IHC-positive at low
magnification (2.5×). Based on the sensitivity of each
organ, the intensity of staining, and the pattern of stain-
ing, sections of kidney, spleen, liver, lung and small intes-
tine were shown to be superior to the heart and brain for
IHC staining for WNV in AMCRs. These results correlate
with Weingartl's findings in experimentally infected crows
[30]. Another important finding in this study was that the
RT-PCR results using formalin-fixed, paraffin-embedded
tissues showed 100% correlation with the results of the
RT-PCR performed on pooled fresh tissue from 48 birds
(43 IHC-positive and 5 IHC-negative birds). The risk of
human exposure to WNV during testing and processing of
tissues is decreased by performing RT-PCR on formalin-
fixed tissues. (Similar to other RNA extraction profiles,
biosafety concerns can also be addressed by immediately
placing fresh tissues into a lysis buffer for RNA extraction.)
The monoclonal antibody, clone 7H2, is specific for an
epitope on Domain III of the envelope (E) protein
[31,32]. This epitope is most likely a conformational
epitope, and therefore, monoclonal antibody sensitivity
may be affected by heat retrieval, formalin fixation and
autolysis. The epitopes targeted by the polyclonal anti-
body are unknown, but most likely include both confor-
mational and linear epitopes on multiple structural
proteins. This could explain the significantly lower sensi-
tivity of the monoclonal antibody compared to the poly-
clonal antibody in this study.
Mosquito-borne transmission is believed to be the most
common form of WNV infection in birds; however, other
routes may also play a role. Our finding of consistent,
intense IHC staining for WNV in sections of small intes-
tine and lung supports the possibility of oral transmis-
sion, as well as gastrointestinal and respiratory shedding,
of the virus in free-ranging AMCRs, as suggested by others
[11,17,30,33-35].
Conclusion
Dead bird surveillance will continue to be an important
tool for the early detection of WNV in a given area and for
guiding control efforts [19,20]. In North America, where
crows have been determined to be the most sensitive sen-
tinel species for detecting WNV, sections of kidney, liver,
lung, spleen and small intestine should be sampled for
IHC testing. Because individual organs can show focal
staining, multiple organs run simultaneously will yield
the most accurate IHC results. Polyclonal antibody IHC
staining should be used for WNV detection in AMCRs
because its sensitivity is comparable to that of RT-PCR
using both fresh and formalin-fixed tissues, as opposed to
monoclonal antibody IHC staining which has a signifi-
cantly lower sensitivity. RT-PCR can accurately be per-
formed using formalin-fixed, paraffin-embedded tissue
sections. In conclusion, we found that, provided appro-
Negative predictive values of IHC antibody staining of spe- cific tissues for WNV, using RT-PCR as a gold standard Figure 3
Negative predictive values of IHC antibody staining of spe-
cific tissues for WNV, using RT-PCR as a gold standard.BMC Infectious Diseases 2007, 7:49 http://www.biomedcentral.com/1471-2334/7/49
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priate tissues are selected, both polyclonal antibody-based
IHC and RT-PCR on formalin-fixed tissues are excellent
methods for the diagnosis of WNV in AMCRs.
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